Key Finding
This will be the first randomized controlled trial to investigate whether acupuncture combined with immune checkpoint inhibitors improves objective response rates in recurrent and metastatic cervical cancer compared to immunotherapy alone.
Researchers are launching a new study to test whether adding acupuncture to immunotherapy treatment can help women with cervical cancer that has returned or spread to other parts of the body. Cervical cancer that comes back or spreads is particularly difficult to treat, and while newer immunotherapy drugs have shown some promise, many patients don't respond to these medications. This study will involve 90 women at multiple medical centers who will be randomly divided into two groups. One group will receive standard immunotherapy treatment alone, while the other group will receive the same immunotherapy plus regular acupuncture sessions. The research team will track several important outcomes, including whether tumors shrink or disappear, how long patients live without their cancer getting worse, overall survival, immune system function, and quality of life. They'll also carefully monitor any side effects from either treatment. The study is based on recent evidence suggesting that acupuncture may help boost immune function in cancer patients, which could potentially make immunotherapy drugs work better. This will be the first randomized controlled trial to examine this combination specifically for recurrent or metastatic cervical cancer. The results could help determine whether acupuncture should be recommended as a complementary treatment alongside immunotherapy for this challenging condition. If you're considering acupuncture for cancer care, work with a licensed acupuncturist experienced in oncology support who coordinates with your cancer treatment team.
This multicenter, open-label RCT will evaluate acupuncture as an adjuvant to immune checkpoint inhibitors (ICIs) in recurrent/metastatic cervical cancer (R/M CC). Ninety participants will be randomized 1:1 to receive either standard ICIs plus acupuncture or ICIs alone for four cycles, with follow-up every 12 weeks for 2 years. The primary endpoint is Objective Response Rate (ORR); secondary endpoints include Progression-Free Survival (PFS), Overall Survival (OS), immune function markers, and quality of life measures. This protocol represents the first randomized investigation of acupuncture's potential to enhance ICI efficacy in R/M CC, addressing the clinical challenge of low ICI response rates. The study design provides preliminary efficacy and safety data to inform larger-scale trials. Practitioners should note this examines acupuncture's immunomodulatory effects in oncology settings, specifically targeting enhancement of checkpoint inhibitor response.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Acupuncture significantly improved total sleep time by approximately 30 minutes and sleep efficiency by 4.56% compared to control groups in breast cancer patients with systemic therapy-associated insomnia.
📌 Cognitive behavioral therapy and hypnosis have the strongest evidence for reducing vasomotor symptoms in breast cancer survivors, while acupuncture may provide modest benefit as an adjunctive nonpharmacological treatment option.
📌 Traditional acupuncture reduced hot flash and night sweat frequency by nearly 50% in breast cancer survivors taking tamoxifen, with sustained effects lasting at least 18 weeks after treatment ended.